Amyris bags another $24.7 million in Series C; synthetic biology gets another boost
August 25, 2009 | Analyst Insight
Emeryville, CA synthetic biology company Amyris Biotechnologies raised $24.7 million in the first close of a Series C this week from existing investors including Khosla Ventures, Kleiner Perkins Caufield & Byers,...
About Lux Research
Lux Research is a leading provider of tech-enabled research and advisory solutions, helping clients drive growth through technology innovation. A pioneer in the research industry, Lux uniquely combines technical expertise and business insights with a proprietary intelligence platform, using advanced analytics and data science to surface true leading indicators. With quality data derived from primary research, fact-based analysis, and opinions that challenge traditional thinking, Lux clients are empowered to make more informed decisions today to ensure future success.